Stevanato Group S.p.A. (NYSE:STVN) Receives Average Rating of “Moderate Buy” from Brokerages

Stevanato Group S.p.A. (NYSE:STVN) has been assigned a consensus rating of “Moderate Buy” from the seven ratings firms that are currently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has assigned a strong buy recommendation to the company.

STVN has been the topic of several research analyst reports. Morgan Stanley raised their target price on shares of Stevanato Group from $24.00 to $26.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 11th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Stevanato Group in a report on Monday.

Institutional Trading of Stevanato Group

A number of hedge funds have recently made changes to their positions in STVN. CIBC Bancorp USA Inc. purchased a new stake in Stevanato Group during the 3rd quarter worth approximately $737,000. Quantessence Capital LLC acquired a new stake in shares of Stevanato Group during the third quarter worth approximately $526,000. Mariner LLC increased its stake in shares of Stevanato Group by 6.9% in the third quarter. Mariner LLC now owns 25,447 shares of the company’s stock worth $655,000 after buying an additional 1,638 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new stake in Stevanato Group in the third quarter valued at $4,155,000. Finally, Bamco Inc. NY raised its holdings in Stevanato Group by 4.5% in the third quarter. Bamco Inc. NY now owns 1,973,759 shares of the company’s stock valued at $50,824,000 after acquiring an additional 85,709 shares in the last quarter.

Stevanato Group Stock Performance

NYSE STVN opened at €23.06 on Friday. The business’s 50-day moving average price is €24.60 and its 200 day moving average price is €24.30. The company has a current ratio of 1.89, a quick ratio of 1.30 and a debt-to-equity ratio of 0.26. Stevanato Group has a twelve month low of €17.81 and a twelve month high of €28.00. The company has a market capitalization of $6.98 billion, a PE ratio of 40.46, a price-to-earnings-growth ratio of 2.25 and a beta of 0.56.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.